takes issue with the entity of the metabolic syndrome, criticizing it on a number of levels, including the seemingly arbitrary selection of its component risk factors and their corresponding cutoff values, the lack of concordance between competing definitions of the metabolic syndrome, and, fundamentally, that the syndrome itself conveys no greater information than the sum of its component risk factors.
Unfortunately, these criticisms detract from the primary utility of the metabolic syndrome as a means of assisting the front-line practitioner in identifying risk factors that require clinical attention. This is especially pertinent for mental health practitioners who have become increasingly aware of the vulnerability of the seriously and persistently mentally ill in developing diabetes and cardiovascular disease and the potential impact of psychotropic medication on this risk (2) . The initial focus of attention had been on monitoring for obesity, but body weight is only one of many parameters that need to be assessed on a routine basis. The concept of the metabolic syndrome allows for a discussion of other important traditional cardiovascular risk factors that require ongoing monitoring such as blood pressure, lipid profile, and glucose. Furthermore, unlike most of the existing cardiovascular risk algorithms, the metabolic syndrome includes consideration of central obesity and serum triglyceride levels. Most psychiatrists are unlikely to calculate Framingham risk scores. Hence, the pragmatic value of the metabolic syndrome is not in studying pathophysiology per se or in designing clinical trials for those who rigidly meet its criteria, but rather the usefulness of the concept is in the ongoing education of practitioners and, ultimately, in the improvement of overall health care (3). A n official and comprehensive analysis on the metabolic syndrome was recently published by Kahn et al. (1) . Taking into consideration not only their own experience but also an impressive list of references, they express some critical ideas regarding the definition, the underlying pathophysiology, and the treatment of this condition. Although the demonstration of Kahn et al. seems very solid, we believe that their conclusions will produce many controversial reactions.
LESLIE CITROME, MD, MPH
In our opinion, the problem of the metabolic syndrome will be significantly simplified if we renounce to consider it first as a cluster of specific cardiovascular risk factors. Otherwise, the debate becomes endless: why include only some cardiovascular risk factors and not include others?
The International Diabetes Federation marked an important progress in the pathophysiology and diagnosis of the metabolic syndrome, suggesting that the key element is central obesity (2) . Unfortunately, in the report of Kahn et al., this very useful observation was minimized.
Generally speaking, all the components of the metabolic syndrome, from all the existing definitions, can be discovered in the picture of obesity. In particular, their concentration is higher in that special form of disease, named central or visceral obesity (3, 4) . Therefore, we can postulate that obesity represents the background of the problem or "the roots of evil"; central obesity is a complex and aggressive form of disease with a huge potential for cardiovascular and metabolic disorders. The metabolic syndrome is, in fact, a complication of this type of obesity. Eventually, we can consider it as a central obesity syndrome. Such a term seems more adequate, both from medical and semantic points of view (5).
DAN MIRCEA CHEŢ A, MD, PHD
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